The other day it was announced that a well known, mega-company discovered a new way to destroy antibiotic resistant bacteria, such as MRSA.  Using nanoparticle technology – which is 50,000 times smaller than a hair’s width – the company’s researchers were able to target an electrical charge on the bacteria’s surface, bursting the membrane open to bring about its demise.

According to the Wall Street Journal, “if successful, [the discovery] would offer a fresh strategy against a worrisome public-health problem of possibly deadly bacteria evolving to become impervious to antibiotics.”   Nearly 19,000 people in the U.S. each year die from drug-resistant MRSA.  Needless to say, this could be a big breakthrough.

Was it Pfizer, Bayer, Merck / Schering-Plough or one of the other great pharmaceutical companies that made the huge discovery?

No.

It was Big Blue – IBM – one of the world’s largest IT firms.

So what, you might say.

Well, we talk a lot about innovation and discovery like it’s just simple math.  And when we see the results, we say, “Oh, yeah, I see.  It’s obvious how ‘x’ could be.”   Yet, when it gets down to it, a lot of discovery is art, accidental, and non-linear.

IBM makes mainframes, software, and provides IT services to individuals and companies across the globe. Though the company has been working on nanotechnology for years, who could have predicted they’d be combating MRSA?  It’s not a drug company.  But, today, it looks like it is (or certainly could be).

This non-linear, man-bites-dog discoverer – IBM as pharma company – holds an important lesson for regulators of technology.

(more…)

I recently took a two-day trip down to Palm Springs to attend an event called “Uncloaking the Kochs” hosted by Common Cause. Accompanied by my dear friend, former assembly candidate Alvaro Day, I traveled as an independent investigative journalist, and not in any official capacity on behalf of Big Government or Breitbart.com (though I was pleasantly surprised to run into a familiar friend of mine on rollerblades jovially inviting everyone to Applebee’s).

Among Common Cause’s, well, common causes, are campaign finance reform, net neutrality, outlawing the filibuster, promoting cap and trade, and in this particular case, herding a mass of protesters outside a nearby hotel to yell at Charles and David Koch for being conservative and rich.

Unfortunately several “haves” have missed the memo that you’re not to be both rich and conservative at the same time, and that bankrolling your pet causes is an extra no-no if you’re conservative—thus exempting left-wing billionaire philanthropists George Soros (from whom Common Cause has received $2 million over the past eight years) Peter Lewis, John Doerr, Julian Robertson, Nicolas Berggruen, and many others from being yelled at too. (more…)

Let’s give the Progressives a rest today. Judging by the 700+ comments on yesterday’s Big Government thread: Media Matters Attacks Beck – Ignores Progressive Roots Of The Klan And Holocaust, it looks like they could use a breather.

Today, we would like to focus on Hitler’s other little helpers: IBM and GM/Opel.

Edwin Black, who authored War Against The Weak, a forensic examination of the Progressive-Eugenic movement, also has written extensively on the role IBM played prior to and during the Nazi Holocaust. From the introduction of War Against The Weak.

From the IBM and the Holocaust website:

(more…)